Evolent Health Inc. (evh 3.5 12/01/29)
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.76avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Evolent Health Inc. (evh 3.5 12/01/29) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Ewing Morris & Co. Investment Partners Ltd. ($8.0M).
- Company
- Evolent Health Inc. (evh 3.5 12/01/29)
- CUSIP
- 30050BAH4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Ewing Morris & Co. Investment Partners Ltd. | 4.17% | No change | 10,500,000 | $8.0M |
"% of holder's portfolio" is EVOLENT HEALTH INC (EVH 3.5 12/01/29)'s weight in each manager's 13F, not the share of Evolent Health Inc. (evh 3.5 12/01/29) the manager owns.